{
    "title": "Astragalus & Longevity",
    "inventor_name": null,
    "publication_year": null,
    "device_name": "TA-65 (cycloastragenol supplement)",
    "goal": "Rejuvenate cells and extend health span by activating telomerase and lengthening telomeres",
    "problem_addressed": "Cellular aging caused by telomere shortening leading to senescence and age-related decline",
    "concept_summary": "TA-65 is a purified cycloastragenol molecule extracted from Astragalus membranaceus that is claimed to activate the hTERT gene, increase telomerase activity, lengthen short telomeres and thereby improve immune function, skin, eyesight and other health-span markers.",
    "detailed_description": null,
    "principles": [
        "Telomerase activation",
        "Telomere lengthening",
        "Gene expression modulation (hTERT)"
    ],
    "scientific_domains": [
        "Molecular Biology",
        "Genetics",
        "Pharmacology",
        "Gerontology"
    ],
    "mechanisms_of_action": [
        "Activation of hTERT gene",
        "Increased telomerase enzyme activity",
        "Elongation of critically short telomeres",
        "Improved DNA damage repair in cells"
    ],
    "materials": [
        "Cycloastragenol (active molecule)",
        "Astragalus membranaceus root extract"
    ],
    "energy_sources": [],
    "inputs": [
        "TA-65 oral capsule (cycloastragenol)",
        "Supplementary nutritional supplements (as part of protocol)"
    ],
    "outputs": [
        "Increased telomerase activity in peripheral blood mononuclear cells",
        "Lengthened telomeres in target cells",
        "Improved immune markers, skin fitness, glucose tolerance, bone density"
    ],
    "claimed_performance": "Improves immune system, skin condition, eyesight, male sexual function; lengthens telomeres; enhances health-span indicators in mice without raising cancer incidence.",
    "experimental_evidence": "Small human study (6 participants) showed telomerase activation in all subjects; in-vitro study demonstrated moderate increase in telomerase activity and T-cell proliferation; mouse dietary study reported health-span improvements (glucose tolerance, osteoporosis, skin fitness) and no significant cancer increase.",
    "replication_status": "Limited; only small-scale human trial and pre-clinical mouse study reported; no large, independent clinical trials documented.",
    "keywords": [
        "telomerase",
        "telomere",
        "anti-aging",
        "Astragalus",
        "cycloastragenol",
        "TA-65",
        "health span"
    ],
    "related_technologies": [
        "Other telomerase-activating nutraceuticals",
        "Telomere-targeting small molecules",
        "Gene therapy for hTERT activation"
    ],
    "controversy_level": "high",
    "confidence_score": 0.7,
    "practicability_score": 0.8,
    "fringe_score": 0.6,
    "evidence_strength": 0.5,
    "risk_score": 0.4,
    "trl_estimate": 4,
    "source_urls": [
        "http://www.wistv.com/Global/story.asp?S=7023619",
        "http://en.wikipedia.org/wiki/Astragalus",
        "http://www.jimmunol.org/cgi/content/meeting_abstract/182/1_MeetingAbstracts/90.30",
        "http://ta65review.org/dr-bill-andrews-on-the-aging-process-pt-1",
        "http://onlinelibrary.wiley.com/doi/10.1111/j.1474-9726.2011.00700.x/full"
    ],
    "organizations": [
        "TA Sciences",
        "RevGenetics",
        "UCLA AIDS Institute",
        "Geron Corporation"
    ],
    "applications": [
        "Anti-aging supplement",
        "Immune-system support",
        "Health-span improvement"
    ],
    "limitations": [
        "Lack of large, peer-reviewed clinical trials",
        "Unclear impact on actual lifespan",
        "Potential theoretical cancer risk from telomerase activation",
        "High cost of protocol ($25,000 per year)"
    ],
    "open_questions": [
        "Does chronic telomerase activation extend human lifespan?",
        "What are the long-term safety implications, especially regarding oncogenesis?",
        "What is the optimal dosage and treatment duration?",
        "Can efficacy be demonstrated in larger, randomized controlled trials?"
    ],
    "red_flags": [
        "Very high price for a year-long protocol",
        "Claims of \"rejuvenation\" with limited independent evidence",
        "Potential conflict of interest (manufacturer-sponsored studies)",
        "Lack of high-impact peer-reviewed publications"
    ],
    "evidence_quotes": [
        "The manufacturers trial of TA-65 shows positive anti-aging benefits.",
        "TA-65 activated telomerase in all samples of subjects tested, while another telomerase activator did not.",
        "TA-65 dietary supplementation in female mice leads to an improvement of certain health-span indicators including glucose tolerance, osteoporosis and skin fitness, without significantly increasing global cancer incidence.",
        "Cycloastragenol moderately increase telomerase activity and proliferative capacity of both CD4 and CD8 T cells.",
        "TA-65 is safe for human consumption."
    ],
    "category": "Longevity & Life Extension"
}